CN116064795A - 确定差异甲基化区域的甲基化状态的方法和试剂盒 - Google Patents

确定差异甲基化区域的甲基化状态的方法和试剂盒 Download PDF

Info

Publication number
CN116064795A
CN116064795A CN202210999151.7A CN202210999151A CN116064795A CN 116064795 A CN116064795 A CN 116064795A CN 202210999151 A CN202210999151 A CN 202210999151A CN 116064795 A CN116064795 A CN 116064795A
Authority
CN
China
Prior art keywords
nos
seq
dmr
methylation
chromosome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210999151.7A
Other languages
English (en)
Chinese (zh)
Inventor
威廉·R·泰勒
大卫·A·阿尔奎斯特
道格拉斯·W·马奥尼
约翰·B·基谢尔
特蕾西·C·亚卜
哈特姆·T·阿拉维
玛丽亚·贾库莫普洛斯
格雷厄姆·P·利德加德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exact Sciences Corp
Mayo Clinic in Florida
Original Assignee
Exact Sciences Corp
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exact Sciences Corp, Mayo Clinic in Florida filed Critical Exact Sciences Corp
Publication of CN116064795A publication Critical patent/CN116064795A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/331—Methylation site specific nuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/627—Detection means characterised by use of a special device being a mass spectrometer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202210999151.7A 2016-09-02 2017-09-01 确定差异甲基化区域的甲基化状态的方法和试剂盒 Pending CN116064795A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662383165P 2016-09-02 2016-09-02
US62/383,165 2016-09-02
CN201780053034.9A CN109790198B (zh) 2016-09-02 2017-09-01 检测肝细胞癌
PCT/US2017/049915 WO2018045322A1 (en) 2016-09-02 2017-09-01 Detecting hepatocellular carcinoma

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201780053034.9A Division CN109790198B (zh) 2016-09-02 2017-09-01 检测肝细胞癌

Publications (1)

Publication Number Publication Date
CN116064795A true CN116064795A (zh) 2023-05-05

Family

ID=61282051

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201780053034.9A Active CN109790198B (zh) 2016-09-02 2017-09-01 检测肝细胞癌
CN202210999151.7A Pending CN116064795A (zh) 2016-09-02 2017-09-01 确定差异甲基化区域的甲基化状态的方法和试剂盒

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201780053034.9A Active CN109790198B (zh) 2016-09-02 2017-09-01 检测肝细胞癌

Country Status (9)

Country Link
US (2) US20180066320A1 (enExample)
EP (2) EP3507298B1 (enExample)
JP (2) JP7293109B2 (enExample)
KR (2) KR102801197B1 (enExample)
CN (2) CN109790198B (enExample)
AU (2) AU2017318700B2 (enExample)
CA (1) CA3034903A1 (enExample)
ES (1) ES2956257T3 (enExample)
WO (1) WO2018045322A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2255198A4 (en) 2008-02-15 2011-05-25 Mayo Foundation DETECTION OF NEOPLASM
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
US11078539B2 (en) 2014-03-31 2021-08-03 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasm
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
EP3274440A4 (en) 2015-03-27 2019-03-06 Exact Sciences Corporation Detecting esophageal disorders
CA3049459A1 (en) 2017-01-27 2018-08-02 Exact Sciences Development Company, Llc Detection of colon neoplasia by analysis of methylated dna
CN111655869B (zh) 2017-11-30 2024-06-28 梅约医学教育与研究基金会 检测乳腺癌
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
JP7680365B2 (ja) * 2019-04-03 2025-05-20 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ 血漿中の膵管腺癌の検出
WO2020214798A1 (en) * 2019-04-17 2020-10-22 The Brigham And Women's Hospital, Inc. Epigenetic signatures of alzheimer's disease
KR102155044B1 (ko) * 2019-10-08 2020-09-11 주식회사 레피다인 생물학적 시료의 간암 조직 기원 여부를 판별하는 방법
KR102103885B1 (ko) * 2019-10-08 2020-04-24 주식회사 레피다인 생물학적 시료의 간 조직 유래 여부를 판별하는 방법
EP4047102A4 (en) * 2019-10-14 2024-04-17 Gencurix Inc. COMPOSITION FOR DIAGNOSIS OF LIVER CANCER USING CPG METHYLATION CHANGES IN SPECIFIC GENES AND USE THEREOF
CN112176419B (zh) * 2019-10-16 2022-03-22 中国医学科学院肿瘤医院 一种检测ctDNA中肿瘤特异基因的变异和甲基化的方法
CA3154354A1 (en) 2019-10-31 2021-05-06 William R. Taylor Detecting ovarian cancer
US20230257821A1 (en) * 2020-01-17 2023-08-17 The Board Of Trustees Of The Leland Stanford Junior University Methods for diagnosing hepatocellular carcinoma
US20230287509A1 (en) * 2020-07-21 2023-09-14 Epigenomics Ag Methods for detecting liver cancer
CN112011619A (zh) * 2020-09-17 2020-12-01 山东大学深圳研究院 Sfrp2作为标志物在乙型肝炎病毒相关肝细胞癌早期诊断中的应用及检测试剂盒
CN114634981B (zh) * 2020-12-16 2024-01-26 广州达健生物科技有限公司 肝癌基因甲基化检测引物探针组合及其试剂盒与应用
EP4278006A4 (en) * 2021-01-12 2025-11-05 Univ Leland Stanford Junior Layered analysis of methylated biomarkers for use in cancer diagnosis and prognosis
CN117355616A (zh) * 2021-05-21 2024-01-05 奥弗奥密克斯生物技术研究与开发股份公司 用于肝细胞癌的dna甲基化生物标志物
WO2023010129A2 (en) * 2021-07-30 2023-02-02 Active Genomes Expressed Diagnostics, Corp. Methods and compositions for treating liver cancer and liver disease
US20240401147A1 (en) * 2021-10-19 2024-12-05 Institut National de la Santé et de la Recherche Médicale Dna methylation signature for diagnosing hepatocellular carcinoma
CN113897434A (zh) * 2021-11-02 2022-01-07 北京艾克伦医疗科技有限公司 鉴定肝癌状态的方法和试剂盒
CN113862370B (zh) * 2021-12-02 2022-03-22 广州滴纳生物科技有限公司 用于筛查肝癌的引物和探针、试剂盒及其应用
CN116287254B (zh) * 2023-02-22 2024-04-30 中国人民解放军海军军医大学 Scrn1在制备肝细胞癌分型诊断或索拉非尼疗效预测试剂盒中的应用
CN116732175A (zh) * 2023-03-09 2023-09-12 江苏鹍远生物技术有限公司 血浆游离dna甲基化标志物在肝脏肿瘤检测中的用途
TW202436629A (zh) * 2023-03-09 2024-09-16 大陸商上海鵾遠健康科技有限公司 血漿游離dna甲基化標誌物在肝臟腫瘤檢測中的用途
CN116200499B (zh) * 2023-03-23 2024-01-19 北京和瑞精湛医学检验实验室有限公司 一种用于肝癌检测的基因组合与相关试剂和应用
WO2024222519A1 (zh) * 2023-04-26 2024-10-31 博尔诚（北京）科技有限公司 用于检测肝癌的组合物及其用途
CN118685520B (zh) * 2024-08-26 2024-11-26 湖南宏雅基因技术有限公司 一种肝癌基因甲基化检测的引物探针组合及试剂盒
CN118834956B (zh) * 2024-09-24 2024-12-06 上海信诺佰世医学检验有限公司 引物和探针组合物、试剂盒及在检测emx1、chfr基因甲基化中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143606A1 (en) * 2000-06-30 2003-07-31 Alexander Olek Diagnosis of diseases associated with the immune system by determining cytosine methylation
US20110217297A1 (en) * 2010-03-03 2011-09-08 Koo Foundation Sun Yat-Sen Cancer Center Methods for classifying and treating breast cancers
WO2014046198A1 (ja) * 2012-09-19 2014-03-27 シスメックス株式会社 肝細胞癌に関する情報の取得方法、ならびに肝細胞癌に関する情報を取得するためのマーカーおよびキット
US20140358448A1 (en) * 2013-05-29 2014-12-04 The University Of Tokyo Computer readable medium for enabling a computer to carry out provision of information on hepatocellular carcinoma and marker and kit for obtaining information on hepatocellular carcinoma
CN104762301A (zh) * 2015-04-24 2015-07-08 武汉大学 一种检测肝癌风险基因tspyl5甲基化水平的试剂盒及方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288609A (en) 1984-04-27 1994-02-22 Enzo Diagnostics, Inc. Capture sandwich hybridization method and composition
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5011769A (en) 1985-12-05 1991-04-30 Meiogenics U.S. Limited Partnership Methods for detecting nucleic acid sequences
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5359100A (en) 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5403711A (en) 1987-11-30 1995-04-04 University Of Iowa Research Foundation Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5639611A (en) 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
CA2036946C (en) 1990-04-06 2001-10-16 Kenneth V. Deugau Indexing linkers
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5849481A (en) 1990-07-27 1998-12-15 Chiron Corporation Nucleic acid hybridization assays employing large comb-type branched polynucleotides
US6872816B1 (en) 1996-01-24 2005-03-29 Third Wave Technologies, Inc. Nucleic acid detection kits
US5846717A (en) 1996-01-24 1998-12-08 Third Wave Technologies, Inc. Detection of nucleic acid sequences by invader-directed cleavage
US5994069A (en) 1996-01-24 1999-11-30 Third Wave Technologies, Inc. Detection of nucleic acids by multiple sequential invasive cleavages
US5338671A (en) 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
AU8102694A (en) 1993-11-17 1995-06-06 Id Biomedical Corporation Cycling probe cleavage detection of nucleic acid sequences
CA2177031A1 (en) 1993-11-30 1995-06-08 Moshe Szyf Inhibition of dna methyltransferase
ATE248224T1 (de) 1994-04-25 2003-09-15 Avitech Diagnostics Inc Die bestimmung von mutationen durch spaltung mit resolvase
US5851770A (en) 1994-04-25 1998-12-22 Variagenics, Inc. Detection of mismatches by resolvase cleavage using a magnetic bead support
EP1260593A3 (en) 1994-12-23 2003-12-03 Dade Behring Inc. Detection of nucleic acids by nuclease-catalyzed product formation
US5882867A (en) 1995-06-07 1999-03-16 Dade Behring Marburg Gmbh Detection of nucleic acids by formation of template-dependent product
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
CA2239683A1 (en) 1995-12-22 1997-07-03 Dade Behring Marburg Gmbh Homogeneous amplification and detection of nucleic acids
US5985557A (en) 1996-01-24 1999-11-16 Third Wave Technologies, Inc. Invasive cleavage of nucleic acids
WO1997039008A1 (en) 1996-04-12 1997-10-23 The Public Health Research Institute Of The City Of New York, Inc. Detection probes, kits and assays
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6096273A (en) 1996-11-05 2000-08-01 Clinical Micro Sensors Electrodes linked via conductive oligomers to nucleic acids
AU7829398A (en) 1997-06-09 1998-12-30 University Of Southern California A cancer diagnostic method based upon dna methylation differences
US6013459A (en) 1997-06-12 2000-01-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
US6063573A (en) 1998-01-27 2000-05-16 Clinical Micro Sensors, Inc. Cycling probe technology using electron transfer detection
WO1999040222A1 (en) 1998-02-04 1999-08-12 Variagenics, Inc. Mismatch detection techniques
US6235502B1 (en) 1998-09-18 2001-05-22 Molecular Staging Inc. Methods for selectively isolating DNA using rolling circle amplification
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US7662594B2 (en) 2002-09-20 2010-02-16 New England Biolabs, Inc. Helicase-dependent amplification of RNA
EP1664077B1 (en) 2003-09-05 2016-04-13 Trustees of Boston University Method for non-invasive prenatal diagnosis
US20080039413A1 (en) * 2003-10-21 2008-02-14 Morris David W Novel compositions and methods in cancer
EP2385143B1 (en) 2006-02-02 2016-07-13 The Board of Trustees of the Leland Stanford Junior University Non-invasive fetal genetic screening by digital analysis
JP2009095262A (ja) 2007-10-15 2009-05-07 Japan Found Cancer Res Ｚｎフィンガータンパク質
CN102301000B (zh) 2008-03-15 2015-04-29 豪洛捷公司 核酸分子扩增反应的分析组分及方法
EP2233590A1 (en) * 2009-01-28 2010-09-29 AIT Austrian Institute of Technology GmbH Methylation assay
US20110256538A1 (en) * 2010-04-15 2011-10-20 Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine Epigenomic dna modifications for tissue typing, early cancer detection, and disease management
US20130237445A1 (en) * 2010-09-14 2013-09-12 The University Of North Carolina At Chapel Hill Methods and kits for detecting melanoma
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
US8715937B2 (en) 2010-11-15 2014-05-06 Exact Sciences Corporation Mutation detection assay
US20130129668A1 (en) * 2011-09-01 2013-05-23 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
WO2013174432A1 (en) * 2012-05-24 2013-11-28 Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) Method for the identification of the origin of a cancer of unknown primary origin by methylation analysis
WO2014052855A1 (en) * 2012-09-27 2014-04-03 Population Diagnostics, Inc. Methods and compositions for screening and treating developmental disorders
EP4234721A3 (en) * 2013-03-14 2023-10-18 Mayo Foundation for Medical Education and Research Detecting neoplasm
CN106232833A (zh) * 2014-01-30 2016-12-14 加利福尼亚大学董事会 用于非侵入性诊断的甲基化单体型分析(monod)
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
EP3034624A1 (en) * 2014-12-18 2016-06-22 Hospital Clínic de Barcelona Method for the prognosis of hepatocellular carcinoma
EP3274440A4 (en) * 2015-03-27 2019-03-06 Exact Sciences Corporation Detecting esophageal disorders
CN109153993B (zh) * 2016-04-14 2023-02-17 梅约医学教育与研究基金会 检测胰腺高度异型增生

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143606A1 (en) * 2000-06-30 2003-07-31 Alexander Olek Diagnosis of diseases associated with the immune system by determining cytosine methylation
US20110217297A1 (en) * 2010-03-03 2011-09-08 Koo Foundation Sun Yat-Sen Cancer Center Methods for classifying and treating breast cancers
WO2014046198A1 (ja) * 2012-09-19 2014-03-27 シスメックス株式会社 肝細胞癌に関する情報の取得方法、ならびに肝細胞癌に関する情報を取得するためのマーカーおよびキット
US20140358448A1 (en) * 2013-05-29 2014-12-04 The University Of Tokyo Computer readable medium for enabling a computer to carry out provision of information on hepatocellular carcinoma and marker and kit for obtaining information on hepatocellular carcinoma
CN104762301A (zh) * 2015-04-24 2015-07-08 武汉大学 一种检测肝癌风险基因tspyl5甲基化水平的试剂盒及方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
XUEPING Q , ET AL.: ""Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance"", DIGESTIVE DISEASES AND SCIENCES, vol. 61, no. 1, 30 January 2016 (2016-01-30), pages 149 - 157, XP035905801, DOI: 10.1007/s10620-015-3878-3 *
YEONJOO J , ET AL.,: ""Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers"", LABORATORY INVESTIGATION, vol. 88, no. 2, 24 February 2008 (2008-02-24), pages 153 - 160, XP055578750, DOI: 10.1038/labinvest.3700706 *
李峰等，: "《分子生物学实验》", 28 February 2015, 华中科技大学出版社, pages: 76 - 77 *

Also Published As

Publication number Publication date
ES2956257T3 (es) 2023-12-18
CA3034903A1 (en) 2018-03-08
KR20190045188A (ko) 2019-05-02
EP4293128A3 (en) 2024-03-20
AU2022291502C1 (en) 2025-08-21
EP3507298A4 (en) 2021-03-10
US20180066320A1 (en) 2018-03-08
JP2019528704A (ja) 2019-10-17
EP3507298A1 (en) 2019-07-10
EP4293128A2 (en) 2023-12-20
JP2023058645A (ja) 2023-04-25
AU2017318700A2 (en) 2020-01-16
AU2017318700A1 (en) 2019-03-14
JP7704792B2 (ja) 2025-07-08
AU2022291502A1 (en) 2023-02-09
AU2017318700B2 (en) 2022-09-22
EP3507298B1 (en) 2023-08-30
KR102648965B1 (ko) 2024-03-18
KR102801197B1 (ko) 2025-04-29
CN109790198B (zh) 2022-09-09
JP7293109B2 (ja) 2023-06-19
AU2022291502B2 (en) 2025-02-20
KR20240038151A (ko) 2024-03-22
CN109790198A (zh) 2019-05-21
WO2018045322A1 (en) 2018-03-08
US20200115761A1 (en) 2020-04-16

Similar Documents

Publication Publication Date Title
JP7704792B2 (ja) 肝細胞癌の検出
US11697853B2 (en) Detecting prostate cancer
US20230028856A1 (en) Detecting gastrointestinal neoplasms
US11542557B2 (en) Detecting colorectal neoplasia
JP2024054246A (ja) 高度膵異形成の検出
CN118910258A (zh) 癌症筛查方法及试剂盒、组合物和系统
AU2020254760A1 (en) Detecting pancreatic ductal adenocarcinoma in plasma
HK40103516A (en) Detecting hepatocellular carcinoma

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination